國立虎尾科技大學 |

Multifaceted Roles of Crystallography in Modern Drug Discovery

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Multifaceted Roles of Crystallography in Modern Drug Discovery/ edited by Giovanna Scapin, Disha Patel, Eddy Arnold.
other author:	Scapin, Giovanna.
Description:	XI, 240 p. 107 illus., 89 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Proteins . -
Online resource:	https://doi.org/10.1007/978-94-017-9719-1
ISBN:	9789401797191

Multifaceted Roles of Crystallography in Modern Drug Discovery
Multifaceted Roles of Crystallography in Modern Drug Discovery[electronic resource] /edited by Giovanna Scapin, Disha Patel, Eddy Arnold. - 1st ed. 2015. - XI, 240 p. 107 illus., 89 illus. in color.online resource. - NATO Science for Peace and Security Series A: Chemistry and Biology,1874-6489. - NATO Science for Peace and Security Series A: Chemistry and Biology,.

Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.

The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.

ISBN: 9789401797191

Standard No.: 10.1007/978-94-017-9719-1doiSubjects--Topical Terms:

1253493
Proteins .

LC Class. No.: QD431-431.7

Dewey Class. No.: 572.6

Multifaceted Roles of Crystallography in Modern Drug Discovery
LDR:04216nam a22004095i 4500 001 967692
003 DE-He213
005 20200701223726.0
007 cr nn 008mamaa
008 201211s2015 ne | s |||| 0|eng d
020 $a 9789401797191 $9 978-94-017-9719-1
024 7 $a 10.1007/978-94-017-9719-1 $2 doi
035 $a 978-94-017-9719-1
050 4 $a QD431-431.7
072 7 $a PSBC $2 bicssc
072 7 $a SCI007000 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 572.6 $2 23
245 1 0 $a Multifaceted Roles of Crystallography in Modern Drug Discovery $h [electronic resource] / $c edited by Giovanna Scapin, Disha Patel, Eddy Arnold.
250 $a 1st ed. 2015.
264 1 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a XI, 240 p. 107 illus., 89 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a NATO Science for Peace and Security Series A: Chemistry and Biology, $x 1874-6489
505 0 $a Preface -- List of Contributors -- Engineering G Protein-Coupled Receptors for Drug Design -- Structural Insights into Activation and Allosteric Modulation of G Protein-Coupled Receptors -- Epigenetic Drug Discovery -- Crystallography and Biopharmaceuticals -- Structural Chemistry and Molecular Modeling in the Design of DPP4 Inhibitors -- Considerations for Structure-Based Drug Design Targeting HIV-1 Reverse Transcriptase.-Protein-Ligand Interactions as the Basis for Drug Action -- The Protein Data Bank: Overview and Tools for Drug Discovery -- Small Molecule Crystal Structures in Drug Discovery -- Protein Aggregation and its Prediction -- Importance of Protonation States for the Binding of Ligands to Pharmaceutical Targets -- Protein-Protein Interactions: Structures and Druggability -- Achieving High Quality Ligand Chemistry in Protein-Ligand Crystal Structures for Drug Design -- Molecular Obesity, Potency and Other Addictions in Drug Discovery -- Adventures in Small Molecule Fragment Screening by X-ray Crystallography for Drug Discovery -- Structure-Based Drug Design to Perturb Function of a tRNA-Modifying Enzyme by Active Site and Protein-Protein Interface Inhibition -- Molecular Interaction Analysis for Discovery of Drugs Targeting Enzymes and for Resolving Biological Function.
520 $a The present work offers a snapshot of the state-of-the-art of crystallographic, analytical, and computational methods used in modern drug design and development. Topics discussed include: drug design against complex systems (membrane proteins, cell surface receptors, epigenetic targets, and ribosomes); modulation of protein-protein interactions; the impact of small molecule structures in drug discovery and the application of concepts such as molecular geometry, conformation, and flexibility to drug design; methodologies for understanding and characterizing protein states and protein-ligand interactions during the drug design process; and monoclonal antibody therapies. These methods are illustrated through their application to problems of medical and biological significance, such as viral and bacterial infections, diabetes, autoimmune disease, and CNS diseases. As approaches to drug discovery have changed over time, so have the methodologies used to solve the varied, new, and difficult problems encountered in drug discovery. In recent years we have seen great progress in the fields of genetics, biology, chemistry, and medicine, but there are still many unmet medical needs, from bacterial infections to cancer to chronic maladies, that require novel, different, or better therapies. This work will be of interest to researchers and policy makers interested in the latest developments in drug design.
650 0 $a Proteins . $3 1253493
650 0 $a Medicinal chemistry. $3 1253747
650 0 $a Molecular biology. $3 583443
650 0 $a Chemistry, Physical and theoretical. $3 557299
650 0 $a Crystallography. $3 583281
650 1 4 $a Protein-Ligand Interactions. $3 882815
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Theoretical and Computational Chemistry. $3 670313
650 2 4 $a Crystallography and Scattering Methods. $3 1142947
700 1 $a Scapin, Giovanna. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066192
700 1 $a Patel, Disha. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066193
700 1 $a Arnold, Eddy. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 889731
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789401797207
776 0 8 $i Printed edition: $z 9789401797245
776 0 8 $i Printed edition: $z 9789401797184
830 0 $a NATO Science for Peace and Security Series A: Chemistry and Biology, $x 1874-6489 $3 1256397
856 4 0 $u https://doi.org/10.1007/978-94-017-9719-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)